asa glp 1 statement glp-1 A narrative review of glucagon-like peptide-1 receptor agonists prior to deep sedation or general anesthesia Anesthetic Considerations for Patients Taking

Structural insights into the activation of GLP-1R by a small molecule agonist

During active weight loss, appetite may decrease, motivation may be high, and progress may be visible

In Summary GLP-1 RAs represent a valuable therapeutic option to achieve weight loss and improve overall health when prescribed safely and appropriately alongside dietary and behavioural support and increased physical activity

Suggested improvements and supplements to guidelines Point-of-care ultrasound (POCUS) has become the de facto option for many centers around the world when assessing patients on GLP-1 RAs before procedures, and many articles assessed in this study have indicated the use of POCUS or other gastric imaging, such as nuclear scintigraphy or gastric motility breath test, in the perioperative setting (Oprea et al

The needles are very small, and most people describe it as less painful than a finger prick for blood sugar testing